The Immunotherapy Landscape in Adrenocortical Cancer
Adrenocortical carcinoma (ACC) is a rare cancer of the adrenal gland that is frequently associated with excess production of adrenal hormones. Although surgical resection may be curative in early-stage disease, few effective therapeutic options exist in the inoperable advanced or metastatic setting....
Main Authors: | Guillaume J. Pegna, Nitin Roper, Rosandra N. Kaplan, Emily Bergsland, Katja Kiseljak-Vassiliades, Mouhammed Amir Habra, Yves Pommier, Jaydira Del Rivero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/11/2660 |
Similar Items
-
The Role of Immunotherapy in the Treatment of Adrenocortical Carcinoma
by: Izabela Karwacka, et al.
Published: (2021-01-01) -
Future prospects for breast cancer immunotherapy
by: V. F. Semiglazov, et al.
Published: (2018-11-01) -
Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance
by: Marta Araujo-Castro, et al.
Published: (2021-03-01) -
Alternative metrics for assessing clinical benefit with immunotherapy in oncology
by: E. Chan, et al.
Published: (2019-10-01) -
Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade
by: Robert W. Wilkinson, et al.
Published: (2018-06-01)